Govt targets 2027 for robotic cancer surgery

During the Barbados Cancer Society’s annual general meeting held at St Michael’s Island Inn Hotel on a recent Thursday evening, Health and Wellness Minister Senator Lisa Cummins laid out a sweeping roadmap to narrow longstanding gaps between public and private oncology care access across the island. The landmark announcement came as the society swore in a new executive team led by newly elected president Sonya Alleyne, alongside immediate past president Professor David Rosin, marking a new chapter for the decades-old patient support and advocacy group.

The centerpiece of Cummins’ policy rollout is the phased introduction of robotic surgical systems for prostate and select gynecological cancer procedures within the public healthcare network, targeted for full launch by 2027. Currently, this precision surgical technology is exclusively accessible to Barbadians with private health insurance, creating a stark two-tier system for life-saving care. The Ministry of Health has already initiated formal partnerships with Northwell Health, New York State’s largest non-profit integrated healthcare network, to execute the rollout. The ministry is finalizing a full inventory of required robotic equipment to include in this year’s national Estimates of Expenditure, while planning structured 10-day training rotations for public sector surgeons, nurses and allied clinical staff at Northwell’s U.S. facilities. Northwell specialists will also travel to Barbados to provide on-site mentorship as the local program scales up.

Cummins also outlined parallel complementary public health upgrades designed to strengthen the full continuum of cancer care. As early as the next fiscal year, which begins this coming April, the ministry plans to roll out population-wide genomic testing in collaboration with international clinical partners, to identify inherited predispositions to a wide range of non-communicable diseases. The move follows feedback from local paediatricians who advocated for expanding screening to include newborn genomic assessments, to flag at-risk children for early intervention. This testing will be integrated into a newly approved national age-tiered non-communicable disease screening program, with scheduled assessments for residents at 20, 30 and 40 years of age, building directly on the Barbados Cancer Society’s existing well-established prostate and breast cancer screening services.

To resolve longstanding shortages of high-cost oncology medications that are currently unavailable on the island, Cummins confirmed Barbados has secured a new collaborative arrangement with the Pan American Health Organization, merging the PAHO Strategic Fund and Revolving Fund to unlock bulk discounted access to specialized cancer treatments for all participating Caribbean nations. Northwell Health has also extended a formal partnership offer to deploy its U.S.-developed early cancer detection blood testing technology for local use, to catch malignancies at far more treatable stages.

Cummins emphasized that early detection tools would deliver no meaningful patient benefit without parallel action to eliminate public sector surgical backlogs. The ministry has already launched formal review sessions with leadership at the Queen Elizabeth Hospital, tasking department heads across clinical units to develop evidence-based triage frameworks to prioritize urgent and time-sensitive cases. Additionally, the hospital board has been directed to evaluate a new patient communication technology platform that will allow patients to customize how their family members receive real-time care updates, including via WhatsApp or email, with plans to launch the system as early as 2025, sharing details on patient assessments, admissions, ward placements and attending clinical teams.

Cummins also called for expanded cross-sector collaboration with the Barbados Cancer Society to develop formal post-acute cancer patient care pathways after hospital discharge, including dedicated support programs for families of children living with cancer. She also flagged the critical unmet need for dedicated mental health support for frontline healthcare workers who routinely navigate the emotional trauma of delivering difficult cancer diagnoses and supporting patients through grueling treatment regimens, noting that the workforce’s unaddressed burnout risk threatens the sustainability of the expanded care programs.

In his outgoing address, immediate past president Professor David Rosin highlighted that the Barbados Cancer Society’s ongoing clinical trials, which combine genomic, DNA and RNA testing alongside conventional prostate and colon cancer screening protocols, are the first of their kind globally. The resulting Barbados Screening Protocol, which drastically reduces or eliminates the false positive results that are a common flaw in standard PSA prostate testing, has already been adopted by dozens of other nations worldwide. Rosin noted that Barbados currently lags roughly 25 years behind global leading nations in standard cancer treatment outcomes, but expressed full confidence that the island would close and eventually surpass that gap, building on its already world-leading screening framework. He also raised a pressing operational concern that the society’s current membership is just one-third of the total count 17 years prior when he first joined, urging all members to leverage word-of-mouth outreach to recruit new participants, encourage more residents to attend routine cancer screening, and expand volunteer support for patients. Rosin also noted that the society may soon benefit from leadership with a non-medical background to bring fresh operational perspectives, while confirming he would remain on the executive council as immediate past president to continue supporting the global clinical trials portfolio and the society’s planned new purpose-built facility.

The newly elected 2025-2027 Barbados Cancer Society executive team includes Justice Cicely P Chase as first vice-president, Dr Shirley Hanoman-Jhagroo as second vice-president, Dr Stephanie Date as honorary secretary, Rueben Blenman as honorary treasurer, and directors Angela Simpson, Juann Ward, Michelle King, Gale Jordan, Dr Greg Padmore and Debbie Fraser.